Globe Life Inc. Set to Report Q1 Results Amid Positive Analyst Outlook

McKinney, Texas-based Globe Life Inc. (GL) specializes in providing life and supplemental health insurance products and annuities for lower-middle and middle-income families. With a market capitalization of around $10 billion, Globe Life operates across various segments, including Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

Upcoming Earnings Announcement

The company plans to release its first-quarter results after the market closes on Wednesday, April 30. Analysts predict that GL will report an adjusted earnings per share (EPS) of $3.24, reflecting a substantial 16.6% increase from the $2.78 reported in the same period last year. Despite missing analysts’ bottom-line estimates once in the past four quarters, Globe Life has exceeded expectations on three other occasions.

Fiscal Projections for Globe Life

For the full fiscal year 2025, analysts anticipate GL will report an adjusted EPS of $13.67, representing a 10.5% rise from the $12.37 recorded in fiscal 2024. Looking ahead to fiscal 2026, earnings are expected to climb further by 10% year-over-year, reaching $15.04 per share.

Stock Performance Overview

Over the past 52 weeks, GL stock has soared 105.2%, significantly outperforming the S&P 500 Index’s ($SPX) 5.5% gains and the Financial Select Sector SPDR Fund’s (XLF) 17.7% returns within the same timeframe.

Mixed Results in Recent Quarter

GL stock fell over 2.5% during the trading session that followed the release of its mixed fourth-quarter results on February 5. The company noted a 4.5% increase in premium collections, achieving $1.2 billion. However, there was a significant decline in realized gains, leading overall revenue to increase only modestly by 3.6% year-over-year to $1.5 billion, missing market expectations by 1%. On a positive note, its non-GAAP net operating income rose 12.1% year-over-year to $3.14 per share, surpassing consensus estimates by 1.3%. After the initial decline, GL stock rebounded with a 2.9% increase in the following trading session.

Analyst Ratings and Future Outlook

The consensus opinion on Globe Life stock is moderately bullish, with an overall rating of “Moderate Buy.” Among the 12 analysts covering the stock, there are seven “Strong Buys,” one “Moderate Buy,” and four “Holds.” The average price target stands at $142, suggesting a potential upside of 17.1% from current levels.

On the date of publication, Aditya Sarawgi did not hold (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article are provided for informational purposes only. For further details, please view the Barchart Disclosure Policy here.

The views expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.